Article • Imaging resource management
Managing the CT contrast media shortage with clinical decision support tools
On March 31st, 2022, a city-wide lockdown to curtail the spread of the Covid-19 virus in Shanghai, China, shuttered the GE Healthcare manufacturing facility that produces 80% of the global supply of iodinated contrast media agents iohexol (Omnipaque) and lodixanol (Visipaque). Although the plant was able to operate at 50% capacity by mid-May, the shutdown resulted in a substantial contrast media…